| Title : Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group - Raskind_2000_Neurology_54_2261 |
| Author(s) : Raskind MA , Peskind ER , Wessel T , Yuan W |
| Ref : Neurology , 54 :2261 , 2000 |
| Abstract : |
| PubMedSearch : Raskind_2000_Neurology_54_2261 |
| PubMedID: 10881250 |
| Title : Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group - Raskind_2000_Neurology_54_2261 |
| Author(s) : Raskind MA , Peskind ER , Wessel T , Yuan W |
| Ref : Neurology , 54 :2261 , 2000 |
| Abstract : |
| PubMedSearch : Raskind_2000_Neurology_54_2261 |
| PubMedID: 10881250 |
| Title : Galantamine in AD: A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group - Raskind_2000_Neurology_54_2261 |
| Author(s) : Raskind MA , Peskind ER , Wessel T , Yuan W |
| Ref : Neurology , 54 :2261 , 2000 |
| Abstract : |
| PubMedSearch : Raskind_2000_Neurology_54_2261 |
| PubMedID: 10881250 |